Dr. Harrington is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
Office of the Dean
1300 York Avenue, F-113
New York, NY 10065Phone+1 212-746-6005- Is this information wrong?
Education & Training
- Duke University HospitalFellowship, Cardiovascular Disease, 1990 - 1993
- UMass Chan Medical SchoolResidency, Internal Medicine, 1986 - 1989
- Tufts University School of MedicineClass of 1986
Certifications & Licensure
- NY State Medical License 2023 - 2025
- CA State Medical License 2012 - 2025
- NC State Medical License 1993 - 2017
- American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- Fellow (FACC) American College of Cardiology
Clinical Trials
- A Clinical Trial to Demonstrate the Efficacy of Cangrelor Start of enrollment: 2006 Apr 01
- Cangrelor Versus Standard Therapy to Achieve Optimal Management of Platelet Inhibition. Start of enrollment: 2006 Sep 01
- A Comparison of Ticagrelor (AZD6140) and Clopidogrel in Patients With Acute Coronary Syndrome Start of enrollment: 2006 Oct 01
- Join now to see all
Publications & Presentations
PubMed
- Variation in Health Status With Invasive vs Conservative Management of Chronic Coronary Disease.Philip G Jones, David J Cohen, Daniel B Mark, Harmony R Reynolds, Jiyan Chen, Jonathan D Newman, Gregg W Stone, Judith S Hochman, , Suzanne V Arnold, David J Maron, Sr...> ;Journal of the American College of Cardiology. 2024 Apr 16
- Apolipoprotein A1 Infusions and Cardiovascular Outcomes after Acute Myocardial Infarction.C Michael Gibson, Danielle Duffy, Serge Korjian, M Cecilia Bahit, Gerald Chi, John H Alexander, A Michael Lincoff, Mark Heise, Pierluigi Tricoci, Lawrence I Deckelbaum...> ;The New England Journal of Medicine. 2024 Apr 6
- Effect of CSL112 on Recurrent Myocardial Infarction and Cardiovascular Death: Insights from the AEGIS-II Trial.Thomas J Povsic, Serge Korjian, M Cecilia Bahit, Gerald Chi, Danielle Duffy, John H Alexander, Dragos Vinereanu, Pierluigi Tricoci, Sojaita Jenny Mears, Lawrence I Dec...> ;Journal of the American College of Cardiology. 2024 Mar 25
- Join now to see all
Journal Articles
- Alirocumab and Cardiovascular Outcomes After Acute Coronary SyndromeVera A Bittner, Kenneth W Mahaffey, Deepak L Bhatt, Robert A Harrington, Gregory G Schwartz, Matthew T Roe, The New England Journal of Medicine
- Impact of Lesion Complexity on Peri-Procedural Adverse Events and the Benefit of Potent Intravenous Platelet Adenosine Diphosphate Receptor Inhibition After Percutaneo...Gregg W Stone, Matthew J Price, Philippe Genereux, C Michael Gibson, Deepak L Bhatt, Robert A Harrington, Kenneth W Mahaffey, European Heart Journal
- Effects of Genetic Variation in Protease Activated Receptor 4 After an Acute Coronary Syndrome: Analysis from the TRACER TrialPaolo Fortina, David J Moliterno, Robert A Harrington, Kenneth W Mahaffey, ScienceDirect
Press Mentions
- Heart Disease After COVID: What the Data SayAugust 2nd, 2022
- Element Science Announces First Patient Save with Jewel Patch Wearable Cardioverter Defibrillator (P-WCD)August 2nd, 2022
- CV Drugs Not Linked to Poor Outcomes in Patients at High Risk for COVID-19August 9th, 2021
- Join now to see all
Professional Memberships
- Member
Hospital Affiliations
- Stanford Health CarePalo Alto, California
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: